Read this article in Français Deutsch Italiano Português Español
Skanska expands role on university’s US$350m biotech institute
16 September 2025
International construction contractor Skanska has secured an additional US$116 million contract with the University of Virginia (UVA) for the Paul and Diane Manning Institute of Biotechnology at Fontaine Research Park in Charlottesville, Virginia, US.
Render of the Paul and Diane Manning Institute of Biotechnology at the University of Virginia. Image: Elkus Manfredi Architects
The award follows a $66 million package announced in May, bringing Skanska’s known 2025 additions on the project to $182 million.
The five-storey, 33,000m² building was budgeted at $350 million in UVA’s capital plan. Related campus investments at Fontaine include a central energy plant, parking garage and roadway improvements valued at more than $140 million.
Designed by Elkus Manfredi, the facility will contain modular laboratories, core facilities and viral-vector manufacturing space, with capacity for 100–150 researchers and partnering biotechnology companies.
Construction began in December 2023 and is scheduled for completion in the fourth quarter of 2027.
STAY CONNECTED
Receive the information you need when you need it through our world-leading magazines, newsletters and daily briefings.
CONNECT WITH THE TEAM
